Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/04/2010US20100281583 Boron transporter
11/04/2010US20100281582 Polypeptides having xylanase activity and polynucleotides encoding same
11/04/2010US20100281579 Methods for Improving Crop Plant Architecture and Yield
11/04/2010US20100281577 Plant haemoglobin
11/04/2010US20100281572 Nematode resistant transgenic plants
11/04/2010US20100281571 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
11/04/2010US20100281570 Maize 18kd oleosin seed-preferred regulatory element
11/04/2010US20100281569 Maize 17kd oleosin seed-preferred regulatory element
11/04/2010US20100281567 Transgenic plants having altered levels of aromatic amino acids and metabolites derived therefrom
11/04/2010US20100281566 Transcriptional control element, chimeric consructs and uses therefor
11/04/2010US20100281555 Method for marking bio-information into genome of organism and organism marked with the bio-information
11/04/2010US20100281552 Synthetic oplophorus luciferases with enhanced light output
11/04/2010US20100281551 Modified transposon vector and its use
11/04/2010US20100281550 Factor involved in latent infection with herpesvirus, and use thereof
11/04/2010US20100281548 Animal models for demyelination disorders
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280412 Anticoagulation Of Human Blood Ex Vivo
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280100 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010US20100280098 Receptor targeted oligonucleotides
11/04/2010US20100280097 Compositions comprising hif-1 alpha sirna and methods of use thereof
11/04/2010US20100280094 Compositions and methods to treat muscular & cardiovascular disorders
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280033 Pyrazole Derivatives
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280011 Dual mechanism inhibitors for the treatment of disease
11/04/2010US20100280006 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
11/04/2010US20100279980 Moenomycin biosynthesis-related compositions and methods of use thereof
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279948 EPIGENETIC MODIFICATIONS AT TNFalpha AS BIOMARKERS FOR SENSITIVITY TO SMAC MIMETIC-INDUCED APOPTOSIS
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279942 Methods for treating motor neuron disease
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
11/04/2010US20100279928 Sldlr in viral hepatitis
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279918 Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents
11/04/2010US20100279415 Lepidopteran insect n-acetylglucosaminidase genes and their use in glycoengineering
11/04/2010US20100279414 Invention concerning the expression and permanent release of canine interleukines
11/04/2010US20100279413 Applications of ubiquinones and ubiquinols
11/04/2010US20100279412 Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
11/04/2010US20100279411 Combinations of proteins to enhance viability of stem cells and their progenitors before transplantation
11/04/2010US20100279410 Compounds for the treatment of proliferative disorders
11/04/2010US20100279409 Method for modifying celluar immune resonse by modulating activin activity
11/04/2010US20100279408 Polymeric short interfering rna conjugates
11/04/2010US20100279407 Alpha 1-acid glycoprotein, alpha 2-hs glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279405 Systems, methods and compositions for optimizing tissue and cell enriched grafts
11/04/2010US20100279404 Method of nuclear reprogramming
11/04/2010US20100279403 Differentiation of pluripotent cells
11/04/2010US20100279402 Expression Construct for Digesting Aggregating Protein and Method of Inhibiting the Aggregation of Aggregating Protein
11/04/2010US20100279401 T Cell Hybridomas And Related Compositions And Methods For Assaying And Modulating T Cell Receptor-Mediated Immune Responses
11/04/2010US20100279400 Diagnostic test for west nile virus
11/04/2010US20100279399 Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use
11/04/2010US20100279398 Instrument and method for treating minor amount of biological material
11/04/2010US20100279384 Isolated reductive dehalogenase genes
11/04/2010US20100279383 Subtilases and subtilase variants having altered immunogenicity
11/04/2010US20100279381 Acetylcholinesterase (AChE) variants of the N-terminus
11/04/2010US20100279380 Methods for Degrading Toxic Compounds
11/04/2010US20100279378 MEK Ligands and Polynucleotides Encoding MEK Ligands
11/04/2010US20100279355 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/04/2010US20100279351 Method for Generation of Antibodies
11/04/2010US20100279350 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
11/04/2010US20100279346 Compositions and Methods for Improved Protein Production
11/04/2010US20100279345 Aut0-inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it
11/04/2010US20100279323 Method for predicting response to epidermal growth factor receptor-directed therapy
11/04/2010US20100279321 Methods and apparatus for the isolation and enrichment of circulating tumor cells
11/04/2010US20100279318 Method of identifying transmembrane protein-interacting compounds
11/04/2010US20100279316 Antibodies to Phosphorylated IRAK4
11/04/2010US20100279313 Novel secreted immunomodulatory proteins and uses thereof
11/04/2010US20100279307 Angiogenesis Inhibiting Molecules, Their Selection, Production and Their Use in the Treatment of Cancer
11/04/2010US20100279292 MicroRNA Expression in Human Peripheral Blood Microvesicles and Uses Thereof
11/04/2010US20100279291 Gene silencing of the brother of the regulator of imprinted sites (boris)
11/04/2010US20100279277 Methods of evaluating a test agent in a diseased cell model
11/04/2010US20100279275 Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
11/04/2010US20100279268 Method for creating perfusable microvessel systems
11/04/2010US20100278996 Soybean Cultivar 86115079
11/04/2010US20100278945 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/04/2010US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card
11/04/2010US20100278893 Implantable material comprising cellulose and the glycopeptide xyloglucan-grgds
11/04/2010US20100278873 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28
11/04/2010US20100278872 Medicaments and methods for treating mesothelioma
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278855 Neuroprotective ganoderma compositions and methods of use
11/04/2010US20100278849 Prostatic acid phosphatase antigens
11/04/2010US20100278847 Mutually suppressive gene/inhibitor combinations for non-antibiotic selection of recombinant strains
11/04/2010US20100278842 Anti-ephb2 antibodies and methods using same
11/04/2010US20100278839 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278832 Anti-bst2 antibody
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278830 Methods and systems for multi-antibody therapies
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
11/04/2010US20100278818 Antibody specific for the Tn antigen for the treatment of cancer
11/04/2010US20100278817 Compounds and methods for the treatment of renal disease
11/04/2010US20100278803 Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
11/04/2010US20100278798 Methods and systems for forming biocompatible materials
11/04/2010US20100278792 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 1827